Abnormal Plasma/Serum Magnesium, Copper, and Zinc Concentrations Associate with the Future Development of Cardiovascular Diseases
Nutrients · 2025
DOI: 10.3390/nu17091447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Boyang Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of St. Andrews, St. Andrews KY16 9TF, UK. Hauptthemen laut MEDLINE: Copper, Magnesium, Zinc, Cardiovascular Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of St Andrews, National Institute for Health and Care Research, School of Medicine, University of St Andrews.
Abstract (Originalsprache)
Background/Objectives: Cardiovascular diseases (CVDs) are the leading cause of global mortality. Major adverse cardiovascular events (MACEs)—such as acute myocardial infarction, stroke, and heart failure—are critical endpoints in the clinical research. The existing research has shown metal ions are important regulators of cardiovascular functioning, and defective metal handling may be associated with an increased risk of CVD. This study examines the association of the plasma/serum levels of magnesium, copper, and zinc with MACE incidence and the prevalence of circulatory system diseases, by using electronic health records from a subset of the Scottish population.
Methods
We categorised individuals by high, low, or normal plasma/serum metal levels, and calculated the percentage of those who subsequently developed a MACE, identified using related International Classification of Diseases, 10th Revision codes from hospital admission records. Logistic regression was employed to analyse the association between pre-event metal ion levels and the development of specific circulatory system disease subgroups.
Results
This study found abnormal magnesium, high copper, and low zinc were associated with a higher risk of developing MACEs. Low magnesium, high copper, or low zinc were associated with increased risks of various circulatory diseases, with specific variations, like low copper increasing venous and lymphatic disease risk.
Conclusions
Our findings suggest abnormal plasma metal profiles are associated with the development of MACEs and circulatory disease events, underscoring the importance of monitoring plasma metal levels for cardiovascular risk management and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of St. Andrews, St. Andrews KY16 9TF, UK.
ORCID-Profile: Boyang Lin, Remi Fritzen, Alan J Stewart, Colin McCowan
Förderung
- University of St Andrews
- National Institute for Health and Care Research
- School of Medicine, University of St Andrews
- Health Informatics Centre at the University of Dundee
Zitieren
APA
Lin, B., Alexander, R., Fritzen, R., Mills, S., Stewart, A. J., & McCowan, C. (2025). Abnormal Plasma/Serum Magnesium, Copper, and Zinc Concentrations Associate with the Future Development of Cardiovascular Diseases. Nutrients. https://doi.org/10.3390/nu17091447
Vancouver
Lin B, Alexander R, Fritzen R, Mills S, Stewart AJ, McCowan C. Abnormal Plasma/Serum Magnesium, Copper, and Zinc Concentrations Associate with the Future Development of Cardiovascular Diseases. Nutrients. 2025. doi:10.3390/nu17091447
BibTeX
@article{Lin2025,
author = {Lin, Boyang and Alexander, Robin and Fritzen, Remi and Mills, Sarah and Stewart, Alan J and McCowan, Colin},
title = {Abnormal Plasma/Serum Magnesium, Copper, and Zinc Concentrations Associate with the Future Development of Cardiovascular Diseases},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17091447}
}
EUVIMED